Skip to main content

Table 4 Efficacy of chemotherapy and pathological findings

From: Outcomes of esophagectomy after chemotherapy with biweekly docetaxel plus cisplatin and fluorouracil for advanced esophageal cancer: a retrospective cohort analysis

  DCF (%), N = 37 bDCF (%), N = 22 p value
Clinical response
 CR/PR/SD/PD 2/21/13/1 0/19/3/0  
 Response rate    0.047
 CR + PR 23 (62.2) 19 (86.4)  
Histological therapeutic effecta    0.312
 Grade 0/1a/1b/2/3 3/16/6/7/5 1/4/6/6/5  
Grade of differentiationa    0.593
 Well differentiated 6 5  
 Moderately differentiated 17 7  
 Poorly differentiated 8 4  
 Not determined 6 6  
Lymphatic vessel invasiona    0.358
 ly0/ly1/ly2/ly3 16/16/2/3 13/7/2/0  
Blood vessel invasiona    0.117
 v0/v1/v2/v3 16/20/1/0 12/7/3/0  
pT stageb    0.542
 T0/Tis/T1/T2/T3/T4a 5/0/6/8/17/1 5/1/5/3/8/0  
pN stageb    0.219
 N0/N1/N2/N3 17/16/3/1 11/8/0/3  
pStageb    0.606
 0/IA/IB/IIA/IIB/IIIA/IIIB/IIIC/IV 5/5/3/5/4/11/1/2/1 4/2/2/3/5/2/0/2/2  
  1. CR complete response, PD progression disease, PR partial response, SD stable disease
  2. aAccording to the Japanese Classification of Esophageal Cancer, 11th edition
  3. bAccording to the UICC classification, 7th edition